Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Kathmandu Univ Med J (KUMJ) ; 21(82): 190-196, 2023.
Article in English | MEDLINE | ID: mdl-38628014

ABSTRACT

Background Headache disorders are among the most prevalent and disabling conditions worldwide. People, however, do not seek early advice in developing countries. Objective To study clinical profile of patients with headache and their existing knowledge, attitude, and practice regarding primary headaches. Method Descriptive cross-sectional study conducted among 196 patients. Patients were selected using purposive sampling technique fulfilling inclusion criteria. Patients were interviewed based on semi-structural headache questionnaire and data was collected from 4th October to 21st December 2021. Descriptive statistics was used for analysis and interpretation. Result Among 196 participants, 74% were females, 29.6% of patients were between (31 to 40) years of age. The majority were Hindu and belongs to province 3; 36.7% were homemakers, and 32.2% were literate. Migraine headache was the most common type with 14.3% reporting aura. Most reported headache within 1 to 5 years. The commonest triggers were sunlight 64.8%, crowd 54.7%, stress 39.8%, fasting state 31.7%, cold 26.3%. Almost 39% believed that headache could be a chronic neurologic disorder. Majority had knowledge of the causes, triggers, and the relieving factors. Fifty-five percent seek help of a doctor for first time, and the rest seek help of a pharmacist or self-medication. Only 19% tried to manage the headache triggers; 66.8% felt that lifestyle modification is the best treatment for headache comparing drugs. Conclusion Migraine headache was the commonest headache occurring at middle age group with sunlight being the most common trigger factor. Lifestyle modification was perceived to be the best for headache management.


Subject(s)
Health Knowledge, Attitudes, Practice , Migraine Disorders , Middle Aged , Female , Humans , Male , Cross-Sectional Studies , Headache/therapy , Headache/etiology , Migraine Disorders/etiology , Surveys and Questionnaires
2.
Kathmandu Univ Med J (KUMJ) ; 20(77): 61-65, 2022.
Article in English | MEDLINE | ID: mdl-36273293

ABSTRACT

Background Cerebral neurocysticerosis is a common parasitic disease of human nervous system but evidence on duration of albendazole therapy and their outcomes in this condition is inadequate Objective To evaluate the impact of varying duration of albendazole therapy on the clinical and radiological outcomes at one month in patients with active solitary neurocysticercosis. Method This is an interventional study conducted at Upendra Devkota Memorial National Institute of Neurological and Allied sciences, Bansbari over 1 year (2017 March - 2018 February). One hundred eighteen patients with new onset seizure secondary to active solitary cysticercal granuloma either received albendazole therapy for 1, 3, 9 or 21 days with the usual care or only received the usual care. Clinical and radiological outcomes were observed at one month follow-up. The difference in the proportion of the outcome measures between intervention and control groups were assessed using chi-square test. Result Our study included 118 patients with male predominance of 61.9%. Albendazole therapy for 3, 9 and 21 days reduced headache by 57.2%, 70.0% and 63.1% respectively which was higher than those with 1-day therapy or without the therapy. This difference in the proportion was statistically significant at p=0.001. Though seizure recurrence also declined but the difference was not significant (p=0.406) between groups. However, at one-month follow-up, majority of patients who received albendazole for 9 days (14, 70%) and 21 days (14, 73.7%) had normal lesion, while most calcified lesion (21, 67.7%) was observed in those who did not receive albendazole therapy. The difference between lesion among the groups was significant (p < 0.001). Conclusion Albendazole therapy in patients with active solitary neurocysticercosis for 9 days is as effective as 21 days and better than 3 days in headache control and lesion dissolution but seizure control could be achieved irrespective of the treatment.


Subject(s)
Albendazole , Neurocysticercosis , Humans , Male , Female , Albendazole/therapeutic use , Neurocysticercosis/diagnostic imaging , Neurocysticercosis/drug therapy , Neurocysticercosis/complications , Seizures/drug therapy , Seizures/etiology , Radiography , Headache
3.
Kathmandu Univ Med J (KUMJ) ; 16(62): 196-198, 2018.
Article in English | MEDLINE | ID: mdl-30636764

ABSTRACT

Cheiro-Oral Syndrome (COS) is a very rare neurological syndrome associated with varied etiology. We report a 53-year-old man presented with left sided perioral and ipsilateral hand/fingers burning sensation for a one-month duration. On examination, he had hypesthesia over left perioral and distal palmar aspect of all five fingers. MRI revealed subacute infarct in the posterior limb of right internal capsule adjacent to and minimally involving thalamus. He was diagnosed as CheiroOral Syndrome as a result of ischemic stroke and managed.


Subject(s)
Hand/physiopathology , Hypesthesia/etiology , Nervous System Diseases/diagnosis , Stroke/complications , Fingers/physiopathology , Humans , Hypesthesia/diagnosis , Magnetic Resonance Imaging , Male , Middle Aged , Mouth , Rare Diseases , Stroke/diagnostic imaging , Syndrome , Thalamus/pathology
4.
Case Rep Neurol Med ; 2016: 8314040, 2016.
Article in English | MEDLINE | ID: mdl-27872776

ABSTRACT

Cerebral venous sinus thrombosis (CVST) is a rare but serious disorder that is associated with a poor clinical outcome. We report a 35-year-old man who had a severe headache and diplopia while climbing Mount Everest. His MR venography showed right transverse and right sigmoid sinus thrombosis. He improved on anticoagulant and symptomatic measures. Cerebral venous sinus thrombosis at high altitude is discussed.

5.
Kathmandu Univ Med J (KUMJ) ; 13(49): 71-3, 2015.
Article in English | MEDLINE | ID: mdl-26620753

ABSTRACT

BACKGROUND: Stroke is common neurological problems in Nepal. The common risk factors for stroke are age, hypertension, diabetes, dyslipidemia and atrial fibrillation. Vitamin D is an emerging risk factors for cardio-cerebrovascular disease. OBJECTIVE: This study is to find out Vitamin D and risk factors in stroke patient in Nepalese population. METHOD: We reviewed the record of 281 stroke patients, admitted to Neurology ward of College of Medical Sciences, Bharatpur, Nepal from 1st January to 31st December 2013. The records were analyzed on the basis of age, sex, hypertension (HTN), body mass index (BMI), smoking habits, hemoglobin(Hb), diabetes mellitus(DM), Lipid profile, Atrial fibrillation(AF) and vascular territory with clinical and radiological evidences. The vitamin D analysis was done all stroke patients. RESULT: Total patient were 281, with male 161 and age range from 18 - 87. Ischemic stroke was noted in 86.8% and hemorrhagic stroke was noted in 13.2% of patients. Middle cerebral artery (MCA) ischemia was noted in 51.5% of patients and anterior cerebral artery (ACA) ischemia was noted in 3% of patients. Multiple infarcts were noted in 12.90% of patients. About half of them were smoker, hypertension 47.40%, Diabetes mellitus 24.20% and 14.1% had atrial fibrillation. 174 (61.92%) of the stroke had less than sufficient Vitamin D. CONCLUSION: The common risk factors for stroke patients like smoking, hypertension, diabetes mellitus and atrial fibrillations are present in Nepalese population. The level of vitamin D was also low in stroke patients.


Subject(s)
Ischemic Attack, Transient/blood , Ischemic Attack, Transient/epidemiology , Stroke/blood , Stroke/epidemiology , Vitamin D/blood , Adult , Aged , Atrial Fibrillation/epidemiology , Biomarkers/blood , Comorbidity , Diabetes Mellitus, Type 2/epidemiology , Dyslipidemias/complications , Female , Humans , Hypertension/epidemiology , Male , Middle Aged , Nepal/epidemiology , Risk Factors , Smoking/epidemiology , Young Adult
6.
JNMA J Nepal Med Assoc ; 53(197): 5-11, 2015.
Article in English | MEDLINE | ID: mdl-26983040

ABSTRACT

INTRODUCTION: Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients. METHODS: The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at admission and at 3 months using National Institute of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) respectively. The outcome parameters were functional independence (mRS≤2) and mortality at three months (mRS=6). Frequency distribution, Mann-Whitney U-test and χ2 test were performed for statistical analysis. RESULTS: Out of 37 patients, 27 (73%) were Smoker, 22 (59.5%) had hypertension and 19 (51.4%) were alcohol consumer. The stroke severity on admission was statistically significant with functional independence (P=0.003) and mortality (P=0.015) at three month. Similarly, Rankin grade on admission was statistically significant with functional independence (P=0.001) and mortality (P=0.048) at three month. At three months, 20 (69%) survived patients were independent while mortality was seen in eight (21.6%) patients. CONCLUSIONS: The management of acute ischemic stroke with combined anti-thrombotic, statins and antihypertensive drugs seems promising and efficacious in mild to moderately severe ischemic stroke.


Subject(s)
Antihypertensive Agents/therapeutic use , Brain Ischemia/drug therapy , Fibrinolytic Agents/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Stroke/drug therapy , Adult , Aged , Aged, 80 and over , Brain Ischemia/diagnosis , Brain Ischemia/mortality , Cross-Sectional Studies , Drug Therapy, Combination , Female , Follow-Up Studies , Hospitals, University , Humans , Male , Middle Aged , Nepal , Prospective Studies , Risk Factors , Severity of Illness Index , Stroke/diagnosis , Stroke/mortality , Survival Analysis , Treatment Outcome
7.
JNMA J Nepal Med Assoc ; 52(195): 935-9, 2014.
Article in English | MEDLINE | ID: mdl-26982669

ABSTRACT

INTRODUCTION: Vitamin D deficiency has been associated with many neurological illnesses. The status of Vitamin D in Nepalese ischemic stroke patients is still unknown. This study aims to assess the status of vitamin D and its association with stroke risk factors in patients with acute ischemic stroke from Central Nepal. METHODS: A total of 60 patients with ischemic stroke were included in the study. Their clinical profile and Vitamin D status were assessed. Frequency distribution, Pearson χ2test and Kruskal-Wallis test were performed for statistical analysis using SPSS-IBM 20. RESULTS: The median (IQR) age of the patient was 65 (53.25, 70.75) years, ranging from 18-87 years. Thirty-four (56.7%) were males. Fourty-eight (80%) patients had hypertension and 34 (56.7%) were smoker. Previous stroke was present in six (10%) cases. Thirty-seven (61.6%) patients had low levels of Vitamin D out of which 26 (43.3%) had vitamin D insufficiency and 11 (18.3%) had vitamin D deficiency. Vitamin D level was significantly associated with previous history of stroke (P=0.043). CONCLUSIONS: Vitamin D deficiency occurs in patients with ischemic stroke. Previous episodes of stroke with low vitamin D levels could be a cause of recurrent strokes. Further studies are necessary to establish the role of vitamin D in acute ischemic stroke in Nepalese population.


Subject(s)
Brain Ischemia , Stroke , Vitamin D Deficiency , Vitamin D/blood , Aged , Brain Ischemia/blood , Brain Ischemia/complications , Brain Ischemia/diagnosis , Brain Ischemia/epidemiology , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Nepal/epidemiology , Recurrence , Risk Factors , Stroke/blood , Stroke/diagnosis , Stroke/epidemiology , Stroke/etiology , Tertiary Care Centers/statistics & numerical data , Vitamin D Deficiency/blood , Vitamin D Deficiency/epidemiology
8.
Kathmandu Univ Med J (KUMJ) ; 11(44): 342-3, 2013.
Article in English | MEDLINE | ID: mdl-24899334

ABSTRACT

With the advancement of neuroradiology, clinical localization followed by radiology, had made neurology more interesting. Vertical gage palsy as presentation cerebrovascular disease is not so common. Vertical gaze palsy usually localizes the lesion to dorsal mid brain. A 56 years male patient presented with sudden onset vertigo, diplopia, transient loss of consciousness and sways toward right side while walking. Clinical examination showed vertical gaze palsy with skew deviation along with swaying towards rt. during walk. MRI brain showed - infarct involving dorsal midbrain at superior colliculus level and medial thalamus.


Subject(s)
Ocular Motility Disorders/diagnosis , Ocular Motility Disorders/physiopathology , Humans , Magnetic Resonance Imaging , Male , Middle Aged
9.
Kathmandu Univ Med J (KUMJ) ; 10(38): 96-9, 2012.
Article in English | MEDLINE | ID: mdl-23132486

ABSTRACT

Three cases of acute intermittent porphyria are reported. While in first case severe pain in abdomen with intermittent exacerbation was the only presentation, the second patient presented as accelerated hypertension and acute abdominal crises in whom the clinical course was characterized by development of deep coma due to inappropriate secretion of antidiuretic hormone before she made complete recovery. The third patient, initially manifested as acute encephalitic syndrome. After initial improvement, she developed features of acute intermittent porphyria i.e. acute abdomen, neuropsychiatric symptoms, and rapidly progressing acute motor neuropathy leading to respiratory and bulbar paralysis. In addition, she developed severe and fluctuating dysautonomia leading to cardiac arrest and fatal termination. The importance of early diagnosis, recognition of autonomic disturbances, prompt treatment and counseling for avoidance of precipitating factors is stressed.


Subject(s)
Inappropriate ADH Syndrome/etiology , Porphyrias/complications , Primary Dysautonomias/etiology , Acute Disease , Adolescent , Adult , Female , Humans , Porphyrias/therapy , Young Adult
10.
Kathmandu Univ Med J (KUMJ) ; 10(37): 91-3, 2012.
Article in English | MEDLINE | ID: mdl-22971872

ABSTRACT

With the advances in neurogenetics association of epilepsy and intellectual disability with chromosomal abnormalities are being increasingly recognized. While onset of seizures with mental retardation at an early age indicate chromosomal abnormality, combination of characteristics facial dysmorphism and congenital abnormalities gives a clue of a particular syndrome. In addition MRI findings may help in confirming the diagnosis. A nine years old boy is presented where early onset seizure, mental retardation, delayed development of speech, presence of facial dysmorphism,, umbilical hernia and undescended testes suggested possibility of chromosomal 6q deletion disorder. Important deletion disorders are discussed and importance of clinical examination is stressed.


Subject(s)
Congenital Abnormalities/epidemiology , Seizures/complications , Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/genetics , Child , Chromosome Deletion , Chromosome Disorders , Chromosomes, Human, Pair 6 , Congenital Abnormalities/diagnosis , Congenital Abnormalities/genetics , Craniofacial Abnormalities , Cryptorchidism/complications , Cryptorchidism/diagnosis , Cryptorchidism/genetics , Facies , Hernia, Umbilical/complications , Hernia, Umbilical/diagnosis , Hernia, Umbilical/genetics , Humans , Intellectual Disability/complications , Intellectual Disability/genetics , Male , Muscular Atrophy/complications , Muscular Atrophy/diagnosis , Muscular Atrophy/genetics , Seizures/diagnosis , Seizures/genetics
11.
JNMA J Nepal Med Assoc ; 49(178): 104-7, 2010.
Article in English | MEDLINE | ID: mdl-21485593

ABSTRACT

INTRODUCTION: Access to hemodialysis is limited in Nepal due to geographical terrain and hemodialysis centers being mostly limited to major city. Therefore, continuous ambulatory peritoneal dialysis is likely to be a better option in Nepal. In 1998, CAPD was initiated in Nepal without success. High rate of peritonitis was cited for failure. Hot tropical climate and poor sense of hygiene among patients was thought to be responsible for the high rate of peritonitis. A new CPD program was started in 2002 in our institute. We reviewed the incidence of peritonitis and factors predisposing. METHODS: All chronic renal failure patients on CAPD since 2002 to 2007 were included in the study. They were followed up for complications and treatment outcome. Patients complicated with peritonitis (N=19) and patients without peritonitis (N=31) were compared. RESULTS: A total of 50 patients were enrolled and mean duration of dialysis was 12 month per patients (Total patients month=600). Twenty six episodes of peritonitis in 19 patients were recorded during this period. Fourteen episode of peritonitis were culture positive. Culture sterile peritonitis was recorded in 12 episodes. Low serum albumin was predisposing factors for peritonitis and peritonitis rate was higher in end stage disease related due to diabetes mellitus. CONCLUSION: Peritonitis rate was comparable in our new program. Thus peritonitis is not a limiting factor for growth of CAPD in Nepal. Hypoalbuminemic and diabetic patients are prone for CAPD related peritonitis.


Subject(s)
Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/epidemiology , Peritonitis/etiology , Acinetobacter Infections/microbiology , Adult , Aged , Aged, 80 and over , Diabetic Nephropathies/complications , Female , Humans , Incidence , Kidney Failure, Chronic/therapy , Male , Middle Aged , Nepal/epidemiology , Peritonitis/microbiology , Prospective Studies , Pseudomonas Infections/microbiology , Serum Albumin/adverse effects , Staphylococcal Infections/microbiology , Streptococcal Infections/microbiology
12.
JNMA J Nepal Med Assoc ; 49(178): 121-8, 2010.
Article in English | MEDLINE | ID: mdl-21485597

ABSTRACT

INTRODUCTION: This study was conducted to explore cardiovascular autonomic neuropathy and its pattern in chronic kidney disease patients. METHODS: Autonomic function using five standard tests was examined in 20 diabetic patients with CKD, 20 age and sex matched diabetic patients without CKD and 20 age and sex matched controls. Analysis of difference between the autonomic function was done in the three groups using Chi-square test or Fischer's test. RESULTS: Total 20 (100%) diabetic CKD patients were found to have autonomic neuropathy. Of these, 2 (10%) patients had early parasympathetic damage, 8 (40%) patients had definite parasympathetic damage, and 10 (50%) patients had combined damage. Heart rate response to standing was statistically significant (p = 0.014) among diabetic CKD patients when compared with diabetic patients without CKD. Combined form of autonomic dysfunction was more frequent in advanced stages of diabetic CKD. Three (42.85%) patients in stage 3 CKD, 4 (66.66%) patients in stage 4 CKD and 5 (71.42%) patients in stage 5 CKD, had combined autonomic failure. CONCLUSIONS: Autonomic neuropathy is common in native Nepalese diabetic CKD patients. Heart rate response to standing is significantly abnormal in diabetic CKD patients in comparison with diabetes mellitus patient without CKD. Severity of autonomic dysfunction increases with severity of CKD..


Subject(s)
Autonomic Nervous System Diseases/diagnosis , Cardiovascular Diseases/diagnosis , Diabetic Nephropathies/diagnosis , Diabetic Neuropathies/diagnosis , Kidney Failure, Chronic/complications , Renal Insufficiency, Chronic/complications , Aged , Autonomic Nervous System Diseases/etiology , Autonomic Nervous System Diseases/physiopathology , Blood Pressure/physiology , Cardiovascular Diseases/etiology , Cardiovascular Diseases/physiopathology , Case-Control Studies , Diabetic Nephropathies/etiology , Diabetic Nephropathies/physiopathology , Diabetic Neuropathies/etiology , Diabetic Neuropathies/physiopathology , Female , Heart Rate/physiology , Humans , Male , Middle Aged , Posture/physiology , Valsalva Maneuver/physiology
13.
J Appl Microbiol ; 105(1): 300-8, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18355231

ABSTRACT

AIMS: To obtain spectinomycin and spectinamine by heterologous expression into the biosynthetic deoxysugar (desosamine) gene-deleted host Streptomyces venezuelae YJ003. METHODS AND RESULTS: The 17-kb spectinomycin biosynthetic gene cluster from Streptomyces spectabilis ATCC 27741 was heterologously expressed into Streptomyces venezuelae YJ003. Furthermore, the speA, speB and spcS2 encoded in the spectinomycin biosynthetic gene cluster of cosmid pSPC8 were also heterologously characterized to be responsible for the production of spectinamine. CONCLUSIONS: The results of this study indicated that pSPC8 contains all the genes necessary for the biosynthesis of spectinomycin. We also concluded that SpeA, SpeB and SpcS2 are sufficient for the biosynthesis of spectinamine. We also verified that SpeB and SpcS2 show dual character in the biosynthetic pathway of spectinomycin in Streptomyces spectabilis. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the report regarding the expression of a biosynthetic gene cluster that gives rise to the production of aminoglycoside antibiotics in Streptomyces venezuelae YJ003. Therefore, this work may serve as a foundation for further research on spectinomycin biosynthesis and other aminoglycosides.


Subject(s)
Aminoglycosides/biosynthesis , Anti-Bacterial Agents/biosynthesis , Bioreactors/microbiology , Multigene Family , Spectinomycin/biosynthesis , Streptomyces/metabolism , Aminoglycosides/genetics , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Bacillus subtilis/drug effects , Genetic Engineering , Microbial Sensitivity Tests , Spectinomycin/chemistry , Spectinomycin/pharmacology , Streptomyces/genetics
14.
Placenta ; 25(7): 637-41, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15193870

ABSTRACT

OBJECTIVE: To study the expression of angiotensin II (ANG II) receptor subtype 1 (AT(1)R) in the human placenta with pregnancy-induced hypertension (PIH). METHODS: Immunohistochemistry was used to detect the expression of AT(1)R in placental tissues of 30 patients with PIH and 10 patients with normal pregnancies (control group). The PIH tissues were further divided into 3 groups: mild PIH group, moderate PIH group and severe PIH group. Each group consisted of 10 patients. A high-resolution pathological image analysis system (HPIAS-1000) was used to determine the quantity of AT(1)R expression. RESULTS: The integral optical density and area of staining in the syncytiotrophoblast (STB) layer and villous endothelium of the placenta were significantly increased in PIH patients, in the moderate and severe PIH groups, as compared with the control group (P < 0.05), indicating that the expression of AT(1)R was highly increased in PIH. However, there was no significant difference between normal pregnancy and the mild PIH group (P > 0.05). Furthermore, statistically significant differences in AT(1)R expression were observed between mild, moderate and severe PIH groups (P < 0.05). CONCLUSION: The expression of AT(1)R is statistically significantly increased in the STB layer and villous endothelium of human placenta with PIH. Expression increases with the severity of the disease. Increased expression may be involved in the pathogenesis of PIH.


Subject(s)
Hypertension, Pregnancy-Induced/metabolism , Placenta/chemistry , Receptor, Angiotensin, Type 1/analysis , Adult , Birth Weight , Chorionic Villi/chemistry , Endothelium, Vascular/chemistry , Female , Gestational Age , Humans , Immunohistochemistry , Parity , Pregnancy , Trophoblasts/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL